IRVINE, Calif., Jun 5, 2008 (UPI via COMTEX) -- A U.S. drug company said it has
developed a cosmetic drug that uses bimatoprost to stimulate eyelash growth.
Allergan Inc., a California company that also makes Botox, said it will file a
new drug application with the U.S. Food and Drug Administration this year.
A clinical trial showed that bimatoprost -- a synthetic prostaglandin analog --
results in significant eyelash growth when applied directly to the base of the
lashes, Allergan said Wednesday in a release.
"We are pleased with the results of our clinical program and believe this
innovative product, if approved, could meet a significant and currently unmet
demand in the medical aesthetic marketplace," Dr. Scott Whitcup, vice president
of research and development, said in a statement.
If approved by the FDA, Allergan's bimatoprost product would be available only
by prescription, the company said.
URL: www.upi.com
Copyright 2008 by United Press International
**********************************************************************
As of Sunday, 06-01-2008 23:59, the latest Comtex SmarTrend® Alert,
an automated pattern recognition system, indicated an UPTREND on
05-29-2008 for AGN @ $55.83.
For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com
SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright © 2004-2008 Comtex News Network, Inc. All Rights Reserved.